Fractyl Health, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +34.2% | +114.6% | -10.4% | -13.3% | -14.8% | -23.2% | -25.3% | +84.3% | +6.2% | -18.1% | -17.5% | |
| – | -23.8% | +249.2% | -14.4% | -17.7% | -18.1% | -34.4% | -43.3% | +198.6% | +9.9% | -24.7% | -24.8% | |
| – | -24.7% | +262.3% | -15.6% | -17.4% | -20.3% | -37.6% | -47.1% | +248.4% | +5.0% | -22.5% | -25.4% | |
| – | -24.7% | +262.3% | -15.6% | -17.4% | -20.3% | -37.6% | -47.1% | +248.4% | +5.0% | -22.5% | -25.4% | |
| – | -8.3% | -31.8% | +46.7% | -100.0% | – | – | – | – | – | – | – | |
| – | -3.9% | +0.0% | -12.3% | +14.1% | +0.0% | -100.0% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +10.3% | -80.2% | -4.6% | +1.2% | +4.0% | -3.8% | +4.6% | +46.4% | -4.7% | -30.3% | +7.2% | |
| – | +33.2% | +18.6% | +7.6% | +10.1% | +25.8% | -4.9% | +16.1% | -14.4% | -1.9% | -15.9% | +2.1% | |
| – | +255.6% | +31.5% | +35.9% | +0.8% | +0.7% | +0.7% | +0.7% | +0.8% | +0.7% | +0.7% | +0.8% | |
| – | -25.9% | +85.7% | +122.7% | -22.7% | +83.4% | -54.4% | +164.4% | -67.8% | +24.8% | +4.8% | -39.0% | |
| – | +0.7% | -48.0% | -1.1% | +6.9% | -0.5% | -2.6% | +2.0% | +2.6% | -0.6% | -1.5% | +1.0% | |
| – | – | – | -15.9% | -28.9% | -43.5% | -77.6% | -385.7% | – | – | +126.0% | -107.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.6% | +0.0% | +0.2% | +1.6% | +0.3% | +2.0% | +29.5% | +137.2% | +3.3% | +0.1% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.